Medicare Enrolled
Dr. Mohsin Bajwa, MD
Pulmonary Disease · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bajwa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bajwa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bajwa
Dr. Mohsin Bajwa is a pulmonary disease specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bajwa performed 3,268 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bajwa received a total of $22,868 from 42 pharmaceutical and/or device companies across 621 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bajwa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in TX
$22,868 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,268
Medicare services
Top 8% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
921 | $97 | $269 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
358 | $170 | $707 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
320 | $92 | $264 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
302 | $141 | $356 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
224 | $30 | $157 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
221 | $44 | $142 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
219 | $45 | $141 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
125 | $135 | $524 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
122 | $63 | $333 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
106 | $65 | $188 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
103 | $11 | $53 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
69 | $0 | $2 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
40 | $4 | $17 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $124 | $422 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
31 | $15 | $37 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 17 | $110 | $295 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
16 | $1,209 | $5,859 |
| New patient office visit, complex (60-74 min) | 15 | $175 | $508 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
13 | $9 | $32 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
12 | $509 | $1,369 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$22,868
Total received (2018-2024)
Avg $3,267/year across 7 years
Top 10% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
621
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,393
2023
$1,368
2022
$959
2021
$418
2020
$9,545
2019
$7,402
2018
$1,783
Payments by company (2024)
Electromed, Inc.
$580
GlaxoSmithKline, LLC.
$175
AstraZeneca Pharmaceuticals LP
$141
Actelion Pharmaceuticals US, Inc.
$85
Biosense Webster, Inc.
$68
Inspire Medical Systems, Inc.
$51
Regeneron Healthcare Solutions, Inc.
$46
Pulmonx Corporation
$40
GENZYME CORPORATION
$40
Philips North America LLC
$33
Insmed, Inc.
$24
ANI Pharmaceuticals, Inc.
$24
Amgen Inc.
$21
Grifols USA, LLC
$19
Bayer Healthcare Pharmaceuticals Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Shionogi Inc
$13
Top 3 companies account for 64.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$12,951
Electromed, Inc.
$1,813
ViiV Healthcare Company
$1,600
Actelion Pharmaceuticals US, Inc.
$1,186
AstraZeneca Pharmaceuticals LP
$972
Mylan Specialty L.P.
$875
Boehringer Ingelheim Pharmaceuticals, Inc.
$649
Genentech USA, Inc.
$422
Philips Electronics North America Corporation
$290
Grifols USA, LLC
$260
Sunovion Pharmaceuticals Inc.
$241
United Therapeutics Corporation
$146
Mallinckrodt LLC
$129
Mallinckrodt Hospital Products Inc.
$107
Allergan Inc.
$104
GENZYME CORPORATION
$95
Regeneron Healthcare Solutions, Inc.
$94
Amgen Inc.
$91
SANOFI-AVENTIS U.S. LLC
$79
Inspire Medical Systems, Inc.
$77
Biosense Webster, Inc.
$68
Pulmonx Corporation
$66
Bayer HealthCare Pharmaceuticals Inc.
$62
Paratek Pharmaceuticals, Inc.
$53
Novartis Pharmaceuticals Corporation
$39
Merck Sharp & Dohme Corporation
$38
Philips North America LLC
$33
Janssen Pharmaceuticals, Inc
$32
JAZZ PHARMACEUTICALS INC.
$32
Mallinckrodt Enterprises LLC
$29
Insmed, Inc.
$24
ANI Pharmaceuticals, Inc.
$24
Horizon Pharma plc
$24
Abbott Laboratories
$21
OptiNose US, Inc.
$20
Janssen Biotech, Inc.
$20
Advanced Respiratory, Inc
$19
Circassia Pharmaceuticals Inc
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
Inogen, Inc.
$17
Gilead Sciences, Inc.
$14
Shionogi Inc
$13
Top 3 companies account for 71.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CARDIOMEMS · CARTO 3 · CHARTIS CATHETER · DUPIXENT · Esbriet · FASENRA · Fetroja · IMBRUVICA · INSPIRE · InogenOne · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · RAYOS · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
122
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE NORTHWEST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bajwa is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bajwa experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Bajwa performed 921 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bajwa receive payments from pharmaceutical companies?
Yes. Dr. Bajwa received a total of $22,868 from 42 companies across 621 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bajwa's costs compare to other pulmonary diseases in Houston?
Dr. Bajwa's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bajwa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Houston
Browse pulmonary diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Electromed, Inc. Payments to Doctors
See all physicians who received payments from Electromed, Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology